India — Fishery/Seafood Products — Squid-Octopus

← back to leaderboard

India received 1 FDA import refusal in Squid-Octopus, part of Fishery/Seafood Products between 2020-Q3 and 2023-Q2. Volume is newly active in the last year. The most-cited issues are Salmonella and filth. No trade baseline is published for this commodity from India, so no per-$1B rate is shown here.

Exporting from India? Get an email when shipments from India are refused at the US border — before your buyers ask.

Key figures

Hazard or paperwork
Of these, 1 were hazard refusals and 0 were paperwork refusals.

Quarterly refusals, last 12 quarters

0 2020-Q3 2020-Q3: 0 — 0 hazard, 0 paperwork 0 2020-Q4 2020-Q4: 0 — 0 hazard, 0 paperwork 0 2021-Q1 2021-Q1: 0 — 0 hazard, 0 paperwork 0 2021-Q2 2021-Q2: 0 — 0 hazard, 0 paperwork 0 2021-Q3 2021-Q3: 0 — 0 hazard, 0 paperwork 0 2021-Q4 2021-Q4: 0 — 0 hazard, 0 paperwork 0 2022-Q1 2022-Q1: 0 — 0 hazard, 0 paperwork 0 2022-Q2 2022-Q2: 0 — 0 hazard, 0 paperwork 0 2022-Q3 2022-Q3: 0 — 0 hazard, 0 paperwork 0 2022-Q4 2022-Q4: 0 — 0 hazard, 0 paperwork 0 2023-Q1 2023-Q1: 0 — 0 hazard, 0 paperwork 2023-Q2: 1 hazard 1 2023-Q2 2023-Q2: 1 — 1 hazard, 0 paperwork

hazard findings labelling & registration

Show the numbers
QuarterRefusalsHazardPaperwork
2020-Q3000
2020-Q4000
2021-Q1000
2021-Q2000
2021-Q3000
2021-Q4000
2022-Q1000
2022-Q2000
2022-Q3000
2022-Q4000
2023-Q1000
2023-Q2110

Recent refusals

Data and downloads

Download all 2 entries (CSV) — every refusal behind this page, with its import division, FDA product code, charges and whether it was a hazard finding or paperwork.

The file holds entries up to 2023-04-13. To get new ones for India by email, watch India.